- Home
- /
- About TargetCancer Foundation
- /
- News & Updates
News & Updates
News from TCF
2025 in Review: A Year of Strength and Growth
TargetCancer Foundation's (TCF) supporters and partners came together in meaningful ways in 2025, illustrating the strength and power of the rare cancer community — one that is accustomed to rising above challenges and obstacles. Our 16th year was a year of growth and...
We Can’t Stop Now — Why We Must Raise Our Voices In Support of Rare Cancer Research
This perspective was written by Kristen Palma, President, TargetCancer Foundation In my life I have had the experience of being a caregiver to a loved one who was diagnosed with a rare cancer with no effective treatment protocol due to lack of research. I have also...
TCF Announces Paying With Our Lives: Save Rare Cancer Research Advocacy Campaign
Speak Out to Save Rare Cancer Research! There’s no such thing as a “good” cancer diagnosis. Hearing the words “you have cancer” unleashes fear, uncertainty, and countless questions. But the path forward can vary drastically. A diagnosis of a common cancer fortunately...
Translating Loss into Discovery: Paul’s Legacy
This reflection was written by Kristen Palma, President, TargetCancer FoundationThis is a story about possibility, even when confronted with an impossible situation. In 2007, I was in love and married to an incredibly smart and loving partner. We had a beautiful baby...
TCF In the News
Strategic Actions for Earlier Recognition and Better Treatment of Rare and Ultra-Rare Cancers
Bio Coffee Chat Offers Advice on Launching a Successful Patient Advocacy Organization
Scientists Build Cell Line Atlas of Deadly Cancers of the Bile Ducts and Gallbladder
Research Spotlight: ‘Cell Line Atlas’ Provides a Crucial Resource for Developing Therapies for Biliary Tract Cancer
Bill Oram: Running a Marathon Won’t Cure Cancer, But it Might Have Saved a Life
Here are all of the charities supported in the 2025 Boston Marathon
Molecular Tumor Boards Improve Precision Medicine Access, but Increasing Patient Reach a Challenge
Rare Cancers - Limited Treatments, Limited Research, Tons of Advocacy
TCF-001 TRACK : A Clinical Trial Studying Precision Medicine in Rare Cancers
Kelly, House Cancer Caucus co-chairs introduce resolution to recognize September 30 as 'Rare Cancer Day'
Creating a Public-Private Partnership to Support Development of Anti-Cancer Therapies for Ultra-Rare Tumor Indications
Leveraging Technology to Streamline Biomarker Testing
Luminary Awards Honor GI Experts, Patient Advocate
Target Cancer Foundation Gala returns to raise money for fight against rare cancers
Local foundation building hope for families facing rare cancer diagnosis
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial - Conquer: the journey informed
TargetCancer Foundation Enrolls First Patient to Decentralized, Rare Cancer TRACK Study
Grief and Survival Sit Side by Side
Research Advocates, Leading Docs to Expand Precision Medicine Access With Decentralized Model
Foundation Medicine, TargetCancer Foundation to test 'precision medicine'
TargetCancer Foundation Announces Rare Cancer Precision Medicine Research Initiative
TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers
Rare Cancers are Common, So Why the Lack of Research Funding?
Mark Your Calendars- October 1 is Rare Cancer Day
Funding a Hopeful Future for Rare Cancer Research
Over coffee, a research collaboration is born
Dancing to Live
Targeting Rare Cancers for Research and Treatment
Cancer Benefit Targets Hope and Healing
Dean & Britta to play TargetCancer benefit
News in Brief: TargetCancer, ATP, Parenthetical Girls, and Unthanks
Media Contact
Kristen Palma
President
[email protected]
617.765.4881